Kiniksa Pharmaceuticals to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) will present at the Morgan Stanley 18th Annual Global Healthcare Conference on September 16, 2020, at 2:00 p.m. ET. A live webcast of the presentation will be available on Kiniksa's website. A replay will be accessible for 14 days post-conference. Kiniksa focuses on developing therapeutic medicines for debilitating diseases and has several clinical-stage product candidates, including rilonacept and mavrilimumab, which aim to address unmet medical needs through innovative approaches.

HAMILTON, Bermuda , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16^th, 2020 at 2:00 p.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.

About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways that are implicated across a spectrum of diseases. For more information, please visit www.kiniksa.com.

Every Second Counts!™ 

Kiniksa Investor and Media Contact
Mark Ragosa
(781) 430-8289
mragosa@kiniksa.com

FAQ

When will Kiniksa Pharmaceuticals present at the Morgan Stanley Healthcare Conference?

Kiniksa Pharmaceuticals will present on September 16, 2020, at 2:00 p.m. ET.

How can I listen to Kiniksa's presentation at the conference?

You can access the live webcast of Kiniksa's presentation through the Investors & Media section of their website.

Will there be a replay of Kiniksa's presentation available?

Yes, a replay of Kiniksa's presentation will be available on their website for 14 days following the conference.

What is the focus of Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals is focused on discovering and developing therapeutic medicines for patients with debilitating diseases and significant unmet medical needs.

What are some of Kiniksa's clinical-stage product candidates?

Kiniksa's clinical-stage product candidates include rilonacept, mavrilimumab, vixarelimab, and KPL-404.